|
1
|
The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
|
Am J Gastroenterol
|
2003
|
3.04
|
|
2
|
Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.
|
Hepatology
|
2010
|
2.30
|
|
3
|
Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury.
|
Gastroenterology
|
2011
|
2.25
|
|
4
|
Liver transplantation for hepatocellular carcinoma.
|
Gastroenterology
|
2005
|
2.15
|
|
5
|
Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death.
|
Liver Transpl
|
2013
|
2.07
|
|
6
|
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
|
Hepatology
|
2011
|
2.01
|
|
7
|
Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
|
Hepatology
|
2013
|
1.81
|
|
8
|
Impact of nighttime and weekend liver transplants on graft and patient outcomes.
|
Liver Transpl
|
2012
|
1.60
|
|
9
|
Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study.
|
Liver Transpl
|
2011
|
1.59
|
|
10
|
Right hepatic lobe donation adversely affects donor life insurability up to one year after donation.
|
Liver Transpl
|
2005
|
1.46
|
|
11
|
Greater travel time to a liver transplant center does not adversely affect clinical outcomes.
|
Liver Transpl
|
2008
|
1.45
|
|
12
|
Local access to subspecialty care influences the chance of receiving a liver transplant.
|
Liver Transpl
|
2013
|
1.43
|
|
13
|
Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation.
|
Ann Surg
|
2010
|
1.13
|
|
14
|
Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.
|
Clin Gastroenterol Hepatol
|
2013
|
1.10
|
|
15
|
Clinical and histopathologic features of fluoroquinolone-induced liver injury.
|
Clin Gastroenterol Hepatol
|
2011
|
1.05
|
|
16
|
The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes.
|
J Clin Gastroenterol
|
2011
|
0.89
|
|
17
|
Depression in primary caregivers of patients listed for liver or kidney transplantation.
|
Prog Transplant
|
2007
|
0.86
|
|
18
|
Surveillance for hepatocellular carcinoma in a Medicaid cirrhotic population.
|
J Clin Gastroenterol
|
2013
|
0.85
|
|
19
|
Hepatocyte senescence in end-stage chronic liver disease: a study of cyclin-dependent kinase inhibitor p21 in liver biopsies as a marker for progression to hepatocellular carcinoma.
|
Liver Int
|
2007
|
0.85
|
|
20
|
Cat scratch disease causing hepatic masses after liver transplant.
|
Liver Int
|
2007
|
0.84
|
|
21
|
Persistent portosystemic shunts after liver transplantation causing episodic hepatic encephalopathy.
|
Dig Dis Sci
|
2009
|
0.84
|
|
22
|
Detective work in drug-induced liver injury: sometimes it is all about interviewing the right witness.
|
Clin Gastroenterol Hepatol
|
2010
|
0.84
|
|
23
|
Effect of ERCP utilization and biliary complications on post-liver-transplantation mortality and graft survival.
|
Dig Dis Sci
|
2010
|
0.83
|
|
24
|
Long-term survival after 67 hours of anhepatic state due to primary liver allograft nonfunction.
|
Liver Transpl
|
2010
|
0.80
|
|
25
|
Re: nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.
|
J Natl Cancer Inst
|
2013
|
0.78
|
|
26
|
Acute liver failure due to iron overdose in an adult.
|
South Med J
|
2005
|
0.76
|
|
27
|
Liver injury in the elderly due to fluoroquinolones: should these drugs be avoided?
|
CMAJ
|
2012
|
0.75
|
|
28
|
New and Evolving Management Paradigms for Hepatitis C after Liver Transplantation.
|
Curr Hepat Rep
|
2011
|
0.75
|
|
29
|
Progress in our understanding of severe drug-induced liver injury.
|
Liver Transpl
|
2009
|
0.75
|
|
30
|
Sustained resolution of fibrosing cholestatic hepatitis C despite viremic relapse after stopping pegylated interferon and ribavirin therapy.
|
Liver Transpl
|
2007
|
0.75
|
|
31
|
Focal fat masquerading as malignancy in the liver graft of a post-transplant patient.
|
Dig Dis Sci
|
2011
|
0.75
|
|
32
|
Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes.
|
J Clin Gastroenterol
|
2017
|
0.75
|
|
33
|
Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast!
|
Postgrad Med
|
2004
|
0.75
|
|
34
|
Appendiceal mucinous tumor.
|
Gastroenterology
|
2002
|
0.75
|
|
35
|
Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.
|
Transplantation
|
2017
|
0.75
|